Literature DB >> 29844594

Sepsis researchers set sights on immunotherapeutic strategies.

Asher Mullard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29844594     DOI： 10.1038/nrd.2018.87

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

Review 1.  Oncology Drug Repurposing for Sepsis Treatment.

Authors:  Izabela Rumienczyk; Maria Kulecka; Małgorzata Statkiewicz; Jerzy Ostrowski; Michal Mikula
Journal:  Biomedicines       Date:  2022-04-17

2.  Selective Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibition by the SCH772984 Compound Attenuates In Vitro and In Vivo Inflammatory Responses and Prolongs Survival in Murine Sepsis Models.

Authors:  Michal Kopczynski; Izabela Rumienczyk; Maria Kulecka; Małgorzata Statkiewicz; Kazimiera Pysniak; Zuzanna Sandowska-Markiewicz; Urszula Wojcik-Trechcinska; Krzysztof Goryca; Karolina Pyziak; Eliza Majewska; Magdalena Masiejczyk; Katarzyna Wojcik-Jaszczynska; Tomasz Rzymski; Karol Bomsztyk; Jerzy Ostrowski; Michal Mikula
Journal:  Int J Mol Sci       Date:  2021-09-22       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.